Related by context. All words. (Click for frequent words.) 77 metastatic malignant 77 leukemia AML 76 Chronic Myeloid Leukemia 75 Meets Primary Endpoint 75 Relapsed Refractory 75 thalidomide Thalomid 75 Cutaneous T 74 Myelodysplastic Syndrome 74 Phase 2b Clinical Trial 74 cetuximab Erbitux R 74 Severe Sepsis 74 SPRYCEL ® 73 Peginterferon 73 Idiopathic Pulmonary Fibrosis 73 recurrent glioblastoma multiforme 73 Investigational Treatment 73 Naive Patients 73 dasatinib Sprycel ® 73 GW# [003] 73 leukemia ALL 73 Chronic Myelogenous Leukemia 73 erlotinib Tarceva ® 73 BARACLUDE ® 73 Aflibercept 73 antibody MAb 73 cell lymphoma CTCL 72 Myelofibrosis 72 Oral Fingolimod 72 Neovascular Age Related Macular 72 abacavir Ziagen 72 Hormone Refractory Prostate Cancer 72 Diffuse Large B 72 Angioedema 72 leukemia CLL 72 Pharmacokinetics PK 72 Orally administered 72 Newly Diagnosed Multiple Myeloma 72 Glioblastoma Multiforme 72 beta 1a 72 Sapacitabine 72 Omacetaxine 72 pan HDAC inhibitor 72 Diabetic Neuropathy 72 Phase 2b Trial 72 Vidaza azacitidine 72 Prolongs Survival 72 Azacitidine 72 Refractory Hodgkin Lymphoma 72 gefitinib Iressa 72 Nilotinib 72 CYT# potent vascular disrupting 72 PKC# 71 Epratuzumab 71 Lupus Nephritis 71 Soft Tissue Sarcoma 71 gastrointestinal stromal tumors GIST 71 myelodysplastic myeloproliferative diseases 71 Tyrosine Kinase Inhibitor 71 Chronic Hepatitis C 71 Intravitreal 71 Nitazoxanide 71 Anti VEGF 71 Diabetic Nephropathy 71 sorafenib Nexavar 71 dasatinib Sprycel 71 Patients Treated With 71 ritonavir boosted 71 ara C 71 Fludarabine 71 Multiple Myeloma MM 71 relapsing multiple sclerosis 71 imatinib Gleevec ® 71 Previously Treated 71 MELAS 71 ZOLINZA 71 topically administered 71 Aliskiren 71 Copegus ribavirin 71 AA Amyloidosis 71 Advanced Melanoma 71 Dasatinib 71 Cell Lymphoma 71 Follicular Lymphoma 71 Lamotrigine 71 Relapsing Multiple Sclerosis 71 Antitumor Activity 71 Atypical Hemolytic Uremic Syndrome 71 relapsed MM 71 Chronic Sinusitis 71 chronic eosinophilic leukemia 71 Adjuvant Treatment 71 invasive candidiasis 71 Pemetrexed 71 Philadelphia Chromosome Positive 71 adalimumab Humira 71 eosinophilic asthma 71 Degarelix 71 Relapsing Remitting Multiple Sclerosis 71 Safinamide 71 Complicated Skin 71 imatinib Gleevec 71 multiple myeloma MM 71 Decitabine 71 familial amyloidotic polyneuropathy FAP 71 Pegylated Interferon 71 Phase IIb Trial 71 Leukemias 71 receptor tyrosine kinase inhibitor 71 Randomized Phase 71 Etanercept 71 adriamycin 71 Malignant Melanoma 70 Angiotensin Converting Enzyme 70 INTEGRILIN R 70 Treated Patients 70 Diabetic Foot Ulcer 70 Investigational Compound 70 haloperidol Haldol 70 basiliximab 70 diarrhea predominant irritable 70 PEG IFN 70 Paraplatin ® 70 Myelodysplastic Syndromes 70 diabetic gastroparesis 70 Tyrosine Kinase Inhibitors 70 secondary hyperparathyroidism 70 ® lenalidomide 70 refractory chronic lymphocytic 70 Pafuramidine 70 Aurora Kinase 70 Non Alcoholic Steatohepatitis 70 Alemtuzumab 70 Elotuzumab 70 prostate cancer HRPC 70 Gleevec resistant 70 R Saizen R 70 pegylated liposomal doxorubicin 70 non splenectomized 70 Doxil ® 70 Bosutinib 70 bevacizumab Avastin ® 70 ribavirin RBV 70 refractory gout 70 Platinol ® 70 Chronic Lymphocytic Leukemia 70 relapsed leukemia 70 Study Evaluating 70 Anthracycline 70 Immunotherapeutic 70 AGGRASTAT R Injection tirofiban 70 oropharyngeal candidiasis OPC 70 Recombinant Human 70 atypical Hemolytic Uremic Syndrome 70 verteporfin 70 mitoxantrone plus 70 Dacogen decitabine 70 Heterozygous Familial Hypercholesterolemia 70 idiopathic thrombocytopenic purpura ITP 70 Acute Myelogenous Leukemia AML 70 alkylating agent 70 Phase IIb Clinical Trial 70 denileukin diftitox 70 Novel Oral 70 PEGylated Fab fragment 70 alfa 2a 70 metastatic castration resistant 70 CTAP# Capsules 70 essential thrombocythemia ET 70 Chronic Hepatitis B 70 Zorbtive TM 70 Pulmonary Arterial Hypertension 70 Interferon Beta 70 Adjunctive Therapy 70 Hepatocellular Carcinoma 70 Chronic Myeloid Leukemia CML 70 cyclophosphamide methotrexate 70 Initiate Clinical Trial 70 Enzastaurin 70 Pivotal Phase III 70 unresectable stage 69 cutaneous T 69 Benign Prostatic Hyperplasia 69 Velcade bortezomib 69 Fingolimod 69 Metastatic Melanoma 69 Achieves Primary Endpoint 69 Tezampanel 69 intranasal formulation 69 IV Busulfex 69 2 methoxyestradiol 69 HQK 69 HLA DR4 69 Laquinimod 69 Allogeneic 69 Mg Usa 69 Dose Ranging Study 69 candesartan cilexetil 69 FTY# fingolimod 69 Posaconazole 69 alefacept 69 complement inhibitor eculizumab 69 malignant ascites 69 Drug Candidate 69 nucleoside analog 69 Hsp# Inhibitor 69 Xyfid TM 69 induce orthostatic hypotension 69 monoclonal antibody conjugated 69 Natalizumab 69 trastuzumab Herceptin ® 69 Tumor Necrosis Factor 69 davunetide intranasal AL 69 Romidepsin 69 dihydrochloride 69 Mycophenolate Mofetil 69 Navelbine ® 69 relapsed multiple myeloma 69 bortezomib Velcade 69 Peginterferon Alfa 2a 69 Pegylated Liposomal Doxorubicin 69 Personalized Immunotherapy 69 Antiviral Therapy 69 Patients Receiving 69 Ziprasidone 69 efalizumab 69 Quinamed 69 ISTODAX ® 69 Phase 2a Trial 69 Enzyme Replacement Therapy 69 Phase 2b Study 69 Renal Cell Carcinoma 69 imipramine Tofranil 69 Nebulized 69 Tacrolimus 69 Advanced Renal Cell 69 Mg Uk 69 Castration Resistant Prostate Cancer 69 formerly LymphoStat B 69 Fluorouracil 69 systemic anaplastic large 69 R lenalidomide 69 somatostatin analog 69 Ribavirin causes 69 acute myeloid 69 Temsirolimus 69 Interferon beta 1a 69 Well Tolerated 69 alpha1 antitrypsin deficiency 69 Initiates Clinical Trial 69 Phase IIa Clinical Trial 69 Sipuleucel T 69 uricase 69 B Cell Lymphoma 69 dacarbazine DTIC 69 Granulocyte Colony Stimulating Factor 69 severe oral mucositis 69 Fluvastatin 69 selective phosphodiesterase 69 Bicalutamide 69 ergot derivatives 69 cetuximab Erbitux ® 69 Noxafil 69 Adjunctive 69 Previously Untreated 69 relapsed ALL 69 IL# PE#QQR 69 SSc 69 Systemic Sclerosis 69 Capecitabine 69 Annamycin 69 acetonide FA 69 Gleevec imatinib mesylate 69 Reminyl galantamine 69 Completes Patient Enrollment 69 lenalidomide Revlimid R 69 Metastatic Prostate Cancer 69 Zarnestra 69 Fulvestrant 69 Amgen Neulasta R 69 metastatic GIST 69 prescribed proton pump 69 VAPRISOL 69 Cloretazine 69 Parathyroid Hormone 69 Relapsed Refractory Multiple Myeloma 69 Phase Ib Clinical Trial 69 recurrent glioblastoma 69 vWD 69 Tiotropium 69 HBeAg + 69 Kinase Inhibitor 69 papillary renal cell carcinoma 69 Microalbuminuria 69 humanised monoclonal antibody 69 PEGylated interferon beta 1a 69 etanercept Enbrel 69 cidofovir 69 Exacerbation 69 Chronic lymphocytic leukemia 69 docetaxel Taxotere ® 69 Clinical Trial Results 69 Progressive Multifocal Leukoencephalopathy 69 FUSILEV enhances 69 mycosis fungoides 69 Mantle Cell Lymphoma 69 overactive bladder syndrome 69 ribavirin Copegus ® 69 Cytotoxic 69 baminercept 69 TNF Tumor Necrosis Factor 69 evaluating tivozanib 69 Phase III Clinical Trial 69 TLK# 69 PEGINTRON TM 69 Metastatic Colorectal Cancer 69 Kepivance 69 Teriflunomide 68 Genentech Rituxan 68 T#I [002] 68 Thromboembolism 68 Inhalation Solution 68 Hepatocellular Carcinoma HCC 68 Receives Orphan Drug Designation 68 Cancidas 68 Aviptadil 68 Phase III Trial 68 ALN HPN 68 Friedreich Ataxia FRDA 68 Hypercholesterolemia 68 Combination Treatment 68 Single Dose 68 RezularTM 68 AZT zidovudine Retrovir 68 Romiplostim 68 vinca alkaloid 68 bevacizumab Avastin R 68 Valopicitabine 68 5 Fluorouracil 68 pentostatin 68 Hodgkin lymphoma NHL 68 biliary tract cancer 68 hyperphenylalaninemia HPA due 68 chronic thromboembolic pulmonary 68 patientswith 68 Mouse Model 68 polycythemia vera essential thrombocythemia 68 Pooled Analysis 68 Sudhir Agrawal D.Phil 68 Unstable Angina 68 Shows Promise Against 68 dual endothelin receptor antagonist 68 paricalcitol 68 Juvenile Idiopathic Arthritis 68 Nucleoside 68 metastatic malignant melanoma 68 Adalimumab 68 IND Application 68 Maribavir 68 sertraline Zoloft 68 erlotinib Tarceva 68 myeloproliferative disorders 68 Bortezomib 68 sunitinib Sutent ® 68 Irinotecan 68 Vaprisol 68 phase IIb trial 68 Tipranavir 68 selective modulator 68 Rheumatoid Arthritis RA 68 Fabry Disease 68 receptor blocker 68 PEGylated anti 68 Renal Impairment 68 itraconazole Sporanox 68 invasive aspergillosis 68 Chronic Myelogenous Leukemia CML 68 atypical hemolytic uremic syndrome 68 Prophylactic Treatment 68 Chronic Prostatitis 68 treat benign prostatic 68 Sevelamer 68 indinavir Crixivan 68 Initiate Phase 68 Pegloticase 68 HBeAg negative patients 68 SHPT 68 Tasimelteon 68 treat chronic sinusitis 68 Flu Cy 68 AVONEX ® 68 II Clinical Trial 68 chronic idiopathic thrombocytopenic purpura 68 Cell Lymphoma CTCL 68 metastatic hormone refractory 68 ACE Inhibitors 68 Cimzia TM 68 Morquio 68 vapreotide acetate 68 E1 INT TM 68 AVAPRO 68 Lenalidomide 68 galiximab 68 Non Alcoholic Fatty 68 LymphoStat B TM 68 lymphoid malignancies 68 BENICAR 68 Captopril 68 humanized monoclonal 68 systemic juvenile idiopathic 68 Antiangiogenic 68 Ropinirole 68 sitaxsentan 68 inhibitor RG# 68 Polymerase Inhibitor 68 FDA Approvals 68 Autologous Stem Cell Transplantation 68 corticosteroid dexamethasone 68 Chronic Heart Failure 68 PsA 68 Pegylated interferon 68 liposomal formulation 68 Vicriviroc 68 Hepatic Encephalopathy 68 novel VDA molecule 68 PROCRIT R 68 Preclinical Models 68 Cytarabine 68 Ischemic 68 Long Term Efficacy 68 generation purine nucleoside 68 Abrupt discontinuation 68 IMiDs ® 68 Rituxan rituximab 68 Prospective Randomized 68 Sprycel dasatinib 68 Xelox 68 Ozarelix 68 trastuzumab Herceptin R 68 Eculizumab 68 ACTEMRA TM 68 orally administered inhibitor 68 Randomized Study 68 MGd 68 Diabetic Macular Edema 68 inhalation powder 68 sunitinib Sutent 68 Initiates Phase II 68 benign prostatic hypertrophy BPH 68 GOUT 68 Plus Ribavirin 68 Monoclonal Antibody 68 Initiates Phase III 68 sitagliptin metformin 68 cinacalcet 68 superficial bladder cancer 68 immune thrombocytopenic purpura ITP 68 rilonacept 68 PAOD 68 Ridaforolimus 68 Nexavar sorafenib 68 Glioblastoma Multiforme GBM 68 Trial Evaluating 68 PF # [002] 68 splenectomized 68 Ceflatonin R 68 Pivotal Trial 68 Controlled Trial 68 Tocilizumab 68 Malignant Glioma 68 small molecule tyrosine 68 targeted radiotherapeutic 68 Vidaza ® 68 Valsartan 68 bone marrow reticulin deposition 68 Oral Mucositis 67 Inhalation Aerosol 67 Ophena TM 67 Kinoid 67 Acute Exacerbations 67 Hypotension 67 Glimepiride 67 Critical Limb Ischemia CLI 67 Acute Myeloid Leukemia 67 Brentuximab Vedotin SGN 67 Adefovir 67 nilotinib Tasigna 67 EVIZON TM 67 developing Bicifadine serotonin 67 Squalamine 67 Successfully Completes Phase 67 AEGR 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 SNT-MC#/idebenone 67 Phase IIA 67 Factor VIIa 67 metastatic renal cell carcinoma 67 hepatorenal syndrome 67 Bronchiectasis 67 fosbretabulin 67 Pivotal Phase 67 Demonstrates Positive 67 fluvastatin 67 Melphalan 67 Leucovorin 67 chronic myeloid 67 intravenously administered 67 Pegylated 67 HBeAg negative 67 Erlotinib 67 Prodrug 67 refractory cutaneous T 67 stage IIIB 67 Chronic Renal Failure 67 Abacavir 67 reslizumab 67 Infected Patients 67 Investigational Oral 67 Acute Ischemic Stroke 67 metastatic colorectal 67 Tanespimycin 67 lapatinib Tykerb 67 Phase III Trials 67 systemic fungal infections 67 Phase 2a Clinical Trial 67 HeFH 67 xanthine oxidase inhibitor 67 8mg/kg 67 ribavirin USP 67 MAGE A3 ASCI 67 lumiliximab 67 Janus kinase 67 hormone refractory metastatic prostate 67 demonstrated antitumor activity 67 lamotrigine Lamictal 67 candidemia 67 Fluconazole 67 NS#/#A protease 67 pancreatic insufficiency 67 chronic immune thrombocytopenic 67 EGFR TKI 67 fistulizing Crohn disease 67 imatinib resistant 67 Leber Hereditary Optic Neuropathy 67 induced macular edema 67 Clolar ® 67 Fixed Dose 67 quetiapine Seroquel 67 ADPKD 67 primary immunodeficiency PI 67 acadesine 67 acute mania 67 alpha 2a 67 Initiates Clinical 67 Cardiotoxicity 67 huN# DM1 67 purpura ITP 67 VFEND 67 diabetic kidney 67 paclitaxel Taxol 67 Darusentan 67 HCV Genotype 67 5 fluorouracil leucovorin 67 Triapine 67 Cyclosporin 67 tenofovir emtricitabine 67 immune thrombocytopenic purpura 67 Bevacizumab 67 Hodgkin lymphoma HL 67 retinal vein occlusion induced 67 JAK Inhibitor 67 investigational oral hepatitis C 67 tumors GIST 67 Combination REOLYSIN R 67 meropenem 67 AAG geldanamycin analog 67 Albuferon TM 67 Acute Myelogenous Leukemia 67 hypereosinophilic syndrome 67 Betaferon R 67 post herpetic neuralgia PHN 67 ZACTIMA 67 Systemic Lupus Erythematosus 67 long acting muscarinic 67 Vascular Disrupting Agent 67 metformin XR 67 Itraconazole 67 Carbamazepine 67 OMP #R# 67 QD dosing 67 thrombocytosis 67 Toxicities 67 oral rivaroxaban 67 Corticosteroid 67 Plicera 67 Fluticasone 67 Mipomersen 67 sJIA 67 occlusion PAO 67 imexon 67 NMIBC 67 PRN FDA Approves 67 terlipressin 67 prostate cancer CRPC 67 Begins Dosing 67 Helicobacter pylori eradication 67 INSPIRE Trial Phase III 67 myeloid metaplasia 67 Initiates Enrollment 67 HuMax EGFr 67 nicardipine 67 rituximab Rituxan 67 Transdermal Patch 67 bladder carcinoma 67 colorectal liver metastases 67 interferon ribavirin 67 Protease Inhibitors 67 prostate cancer mCRPC 67 Presents Preclinical Data 67 gamma secretase inhibitor 67 Bucindolol 67 visilizumab 67 Neulasta ® 67 nucleotide analogue 67 Rindopepimut 67 cisplatin gemcitabine 67 busulfan 67 Epidermal Growth Factor Receptor 67 Eltrombopag 67 Protease Inhibitor 67 cromolyn sodium 67 orally inhaled migraine 67 ThermoDox R 67 anagrelide 67 recurrent genital herpes 67 CYP#A# CYP#D# 67 Haptoglobin 67 mycophenolate mofetil 67 midstage clinical 67 sorafenib tablets 67 Pivotal Study 67 Janssen Risperdal 67 TAXOTERE R 67 Peripheral Arterial 67 Lymphocytic 67 Combination Therapy 67 Retreatment 67 Monopril 67 refractory acute myeloid 67 voriconazole 67 flutamide 67 Overactive Bladder 67 Polyneuropathy 67 Efficacy Trial 67 Chemotherapy Induced 67 Tarceva TM 67 Placebo Controlled Study 67 abacavir lamivudine 67 RhuDex 67 Muraglitazar 67 Interferon alfa 67 TRO# 67 Bosentan 67 HDAC Inhibitor 67 CLL SLL 67 insulin glulisine 67 YONDELIS 67 Neovascularization 67 Improves Survival 67 Fludara ® 67 fallopian tube carcinoma 67 rFVIIa 67 Monotherapy 67 bullous 67 palifermin 67 dalteparin 67 Valproic acid 67 Syncria R 67 metastatic gastric 67 Ecallantide 67 Sandostatin R 67 bortezomib Velcade R 67 LHON 67 See CLINICAL PHARMACOLOGY 67 SYN# 67 mesylate 67 peginterferon alpha 2a 67 Renal Anemia 67 BENLYSTA TM 67 MKC# MT 67 Adjuvant Chemotherapy 67 rivastigmine Exelon 67 Idiopathic Pulmonary Fibrosis IPF 67 Cinquil 67 Mitoxantrone 67 leukotriene receptor antagonist 67 selective antagonist 67 pegylated interferon alpha 67 Antiviral Activity 67 pan histone deacetylase 67 receiving prophylactic anticoagulation 67 HIV HCV coinfected 67 soluble tumor necrosis 67 Moxifloxacin 67 Primary Hypercholesterolemia 67 biologic DMARD 67 Myeloid 67 Chronic Constipation 67 targeted antifolate 67 mapatumumab 67 trial evaluating PRX# 67 Chronic Lymphocytic Leukemia CLL 67 Campath alemtuzumab 67 olmesartan 67 refractory NSCLC 67 Bazedoxifene 67 AVASTIN 67 Cethromycin 67 Alinia 67 TNF Blockers 67 lymphocytic leukemia 67 Acute Myeloid Leukaemia AML 67 virus HCV protease inhibitor 67 pioglitazone HCl 67 Chemoradiation 67 capecitabine Xeloda 67 INCB# [003] 67 CTAP# 67 Gemzar ® 67 Liprotamase 67 venlafaxine Effexor 67 idiopathic myelofibrosis 67 Liver Failure 67 chimeric monoclonal antibody 67 HER2 Positive Breast Cancer 67 Galantamine 67 Teriparatide 67 Thrombotic 67 rhIGF-I/rhIGFBP-3 67 FOLOTYN ® 67 Cetrorelix 67 Peginterferon alfa 2b 67 Demonstrates Significant 67 Dyskinesia 67 idiopathic thrombocytopenic purpura 67 virus HCV 67 Fenretinide 67 Files IND 67 PRT# 67 Cytochrome P# 66 Lubiprostone 66 kidney urologic 66 FOLFOX6 66 J Am Coll 66 K ras mutations 66 Hemorrhagic 66 MIRAPEX ER 66 Cannabinor 66 Ph + acute lymphoblastic 66 haematologic malignancies 66 adefovir dipivoxil 66 steroid refractory ulcerative 66 BARACLUDE R 66 nucleotide analog 66 achieved CCyR 66 Pulmonary Arterial Hypertension PAH 66 OHR/AVR# 66 β blockers 66 Squamous 66 Hydralazine 66 RhuDex ® 66 Treatment Resistant 66 essential thrombocythemia 66 refractory AML 66 aripiprazole Abilify 66 hematological malignancy 66 SAR# [002] 66 BCR ABL inhibitor 66 platelet inhibitor 66 smoldering myeloma 66 Occlusive Disease 66 Replacement Therapy 66 Telbivudine 66 Systemic Lupus Erythematosus SLE 66 PRTX 66 Fondaparinux 66 EFFEXOR XR 66 gastrointestinal stromal tumor 66 ceftazidime 66 Amgen Neulasta ® 66 5 FU leucovorin 66 Sclerosing 66 idiopathic pulmonary fibrosis IPF 66 Torisel temsirolimus 66 malignant lymphomas 66 oxaliplatin Eloxatin 66 TO AVOID PREGNANCY WHILE 66 cardiotoxic 66 panobinostat 66 gastrointestinal stromal tumor GIST 66 Gastrointestinal Stromal Tumors 66 Waldenstrom macroglobulinemia 66 PROSTVAC VF 66 Granted Orphan Drug 66 Vandetanib 66 MTP inhibitor 66 imatinib mesylate 66 Hydroxyurea 66 PPAR gamma agonist 66 tarenflurbil 66 relapsing remitting MS RRMS 66 AEG# 66 decitabine 66 cediranib 66 smoldering multiple myeloma 66 Sulfonylurea 66 Cyclophosphamide 66 Pertuzumab 66 calcineurin inhibitor 66 Talabostat 66 vinorelbine tartrate 66 demethylating agent 66 mRCC 66 cancer neuroendocrine tumor 66 Bipolar Mania 66 oblimersen 66 refractory myeloma 66 Navelbine 66 Interferon beta 66 thrombotic thrombocytopenic purpura 66 JAK2 Inhibitor 66 cis retinoic acid 66 Intravenous immunoglobulin 66 investigational protease inhibitor 66 Voreloxin 66 antiangiogenic agent 66 VICTOR E3 66 intravenous immunoglobulin IVIg 66 multikinase inhibitor 66 NAGS deficiency 66 beta interferons 66 Treatment Naïve 66 posterior uveitis 66 NAVISTAR R 66 immunomodulatory agents 66 overt nephropathy 66 SGPT 66 ziconotide 66 Cypher Sirolimus 66 sodium glucose cotransporter 66 INCB# [001] 66 Gemzar gemcitabine 66 Glatiramer Acetate 66 Allergic Rhinitis 66 phase IIb clinical 66 caspofungin 66 Antiplatelet 66 Copegus ® 66 Telithromycin 66 Parnate 66 Carbidopa 66 pediatric acute lymphoblastic 66 Myocardial Ischemia 66 Atopic Dermatitis 66 Nesiritide 66 Thiazolidinediones 66 neutropenia dehydration dyspnea 66 Remicade infliximab 66 catheter occlusion 66 PROCRIT ® 66 phase III isavuconazole 66 advanced hepatocellular carcinoma 66 arthritis PsA 66 acute PAO 66 relapsed acute myelogenous 66 schizophrenia CIAS 66 #mg/#mg 66 Hepatotoxicity 66 Rheumatoid 66 peritumoral brain edema 66 Immunomodulatory 66 overactive bladder OAB 66 anthracycline taxane 66 tigecycline 66 Janus Kinase 66 Pegasys ® 66 Interferon alpha 66 Boceprevir 66 Hematologic 66 Orally Active 66 Treatment Naive Patients 66 BCG refractory carcinoma 66 refractory ovarian cancer 66 cilengitide 66 haematologic 66 HoFH 66 Azathioprine 66 citalopram Celexa 66 hour bronchodilation 66 psoriatic arthritis PsA 66 octreotide implant 66 assessing T DM1 66 malignant pleural mesothelioma 66 Soriatane 66 oral prodrug 66 Demonstrates Efficacy 66 luteinizing hormone releasing 66 Paliperidone Palmitate 66 Tigecycline 66 relapsed refractory multiple myeloma 66 Trandolapril 66 Slow Progression 66 Dapagliflozin 66 Temodar ® 66 Antigen Specific 66 Torisel 66 brimonidine 66 Kamada AAT 66 oxypurinol 66 Drug Shows Promise 66 liposomal amphotericin B 66 Xanafide 66 carbamazepine Tegretol 66 refractory chronic myeloid 66 systemic lupus erythematosus psoriasis 66 KRN# 66 ankylosing spondylitis AS 66 taxane resistant 66 nutlin 3a 66 dexamethasone Decadron 66 metastatic neuroendocrine tumors 66 Shows Efficacy 66 anterior uveitis 66 FOLFOX4 66 alfuzosin 66 Improves Outcomes 66 Patients Treated 66 Thrombocytopenia 66 FOLFOX chemotherapy 66 Submits NDA 66 Deforolimus 66 Alkeran 66 tazobactam 66 eritoran 66 IV NSCLC 66 Inflammatory Markers 66 Radiofrequency Ablation RFA 66 Saizen ® 66 Exemestane 66 omalizumab Xolair 66 Hypertensive Patients 66 DU #b 66 non nucleoside inhibitor 66 azilsartan medoxomil 66 Novel Therapeutic 66 HCV Protease Inhibitor 66 Lymphoid 66 Desmopressin 66 severe neutropenia 66 BENICAR HCT 66 Rotigotine 66 Anti Tumor 66 alpha interferons 66 STELARA TM 66 Antitumor activity 66 Severe Primary IGFD 66 Phase III Pivotal 66 fumarate 66 Simulect 66 dextromethorphan quinidine 66 neurogenic bladder 66 MEVACOR 66 headache nasopharyngitis 66 Tolvaptan 66 uremic pruritus 66 pentoxifylline 66 J Clin 66 Acute Myeloid Leukemia AML 66 administered subcutaneously 66 CDK inhibitor 66 Telmisartan 66 tyrosine kinase inhibitors TKIs 66 abatacept Orencia 66 basal cell carcinoma BCC 66 Hepatitis C Genotype 66 antimetabolite 66 Neoadjuvant 66 pemphigus vulgaris 66 Completes Enrollment 66 Shows Statistically Significant 66 protein tyrosine phosphatase 1B 66 Medoxomil 66 Pazopanib 66 Aricept donepezil 66 imatinib resistance 66 Inflammatory Diseases 66 lupus erythematosus 66 efavirenz EFV 66 T2DM 66 Blinatumomab